Short communication · Sep 2020
Conference abstractPublished 29 Nov 2011
Interferon lambda: A new sword in cancer immunotherapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Human umbilical cord blood-derived msenchymal stem cell (hUCB-MSC) has been regarded as a fascinating candidate of stem cell therapy in neurodegenerative disorders such as alzheimer?s disease (AD). Recently, many groups reported that mesenchymal stem cell is a robust source, not only of regeneration but also of secretion of various soluble factors for damaged or lost host cells. Since we also have been observed paracrine action of hUCB-MSC under a certain pathological condition, we tested whether hUCB-MSC provides therapeutic action against amyloid β (Aβ) neurotoxicity in vitro and in vivo. hUCB-MSC removed Aβ42 signifi cantly through induction of neprilysin expression, Aβ degrading enzyme in microglia cells via paracrine action. We also identifi ed paracrine factors which were secreted from hUCB- MSC to induce neprilysin in microglia. Moreover, the same result was confi rmed in a transgenic mice model of AD. Based on these fi ndings, we received a clearance from Korea Food and Drug Administration (KFDA) and are performing Phase I clinical trial in Korea. In this presentation, I will briefl y introduce our eff orts to develop hUCB-MSC therapeutics for AD from the bench to clinical trial.
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2018
Evidence for a widespread effect of interferon lambda 4 on hepatitis C virus diversity
Conference abstract · 28 Sep 2015
Expression of IFN-Lambda receptor (IFN-λRa) in mononuclear phagocyte cells (MPC) and its influence by the levels of newly discovered type III interferon lambda 4 (in Vitro study)
Perspective · 26 Feb 2025
Immunotherapy for Autoimmune Diseases: A Double-edged Sword?
Editorial · 2012
A New Ally for Interferon-alpha in Cancer Therapy
More from this journal
The newest in Journal of Cell Science & Therapy.
Perspective · 2 Feb 2026
Exploring Senescence and Its Influence on Tissue Function and Therapeutic Research
Commentary · 2 Feb 2026
Metabolism Regulation and Its Influence on Therapeutic Development in Human Disease
Commentary · 2 Dec 2025
Cellular Membranes and Transport Proteins as Regulators of Homeostasis and Metabolic Coordination
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cell Science & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Ahmed Lasfar”
- BylineArticles whose byline prints “Walid Abushahba”
- BylineArticles whose byline prints “Murugabaskar Balan”
- BylineArticles whose byline prints “Karine A. Cohen-Solal”

